NOVOZYMES A/S SPONS.ADR 1 Cash Flow Conversion Efficiency

Latest as of March 2026: 0.015x

NOVOZYMES A/S SPONS.ADR 1 cash flow conversion efficiency. Based on the latest financial reports, NOVOZYMES A/S SPONS.ADR 1 (NZM) has a cash flow conversion efficiency ratio of 0.015x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€167.10 Million ≈ $195.36 Million USD) by net assets (€10.92 Billion ≈ $12.77 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NOVOZYMES A/S SPONS.ADR 1 (NZM) total market value for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of NOVOZYMES A/S SPONS.ADR 1 (2021–2025)

Cash flow conversion efficiency of NOVOZYMES A/S SPONS.ADR 1 from 2021 to 2025. This chart illustrates how NOVOZYMES A/S SPONS.ADR 1's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of NOVOZYMES A/S SPONS.ADR 1 for real-time trading data and today's change.

NOVOZYMES A/S SPONS.ADR 1 Cash Flow Conversion Ratio Explained

NOVOZYMES A/S SPONS.ADR 1 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

NOVOZYMES A/S SPONS.ADR 1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NOVOZYMES A/S SPONS.ADR 1 ranked by their cash flow conversion efficiency. Review NZM FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
Fresnillo plc
F:FNL
0.020x
Expeditors International of Washington, Inc.
NYSE:EXPD
0.084x
NATURGY ENERGY ADR1/5/E01
F:GANA
0.136x
InterContinental Hotels Group PLC
LSE:IHG
-0.215x
First Citizens BancShares, Inc.
NASDAQ:FCNCA
0.048x
Principal Financial Group Inc
NASDAQ:PFG
0.161x
Las Vegas Sands Corp
NYSE:LVS
0.623x
Repsol S.A
F:REPA
0.036x

Annual Cash Flow Conversion Efficiency for NOVOZYMES A/S SPONS.ADR 1 (2021–2025)

The table below shows the annual cash flow conversion efficiency of NOVOZYMES A/S SPONS.ADR 1 from 2021 to 2025. Also see balance sheet size of NOVOZYMES A/S SPONS.ADR 1 for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €10.86 Billion
≈ $12.69 Billion
€1.22 Billion
≈ $1.43 Billion
0.113x +23.31%
2024-12-31 €11.18 Billion
≈ $13.07 Billion
€1.02 Billion
≈ $1.19 Billion
0.091x -68.46%
2023-12-31 €1.93 Billion
≈ $2.25 Billion
€557.10 Million
≈ $651.31 Million
0.289x +2.75%
2022-12-31 €1.91 Billion
≈ $2.23 Billion
€537.65 Million
≈ $628.57 Million
0.282x -15.39%
2021-12-31 €1.64 Billion
≈ $1.92 Billion
€546.17 Million
≈ $638.53 Million
0.333x --

About NOVOZYMES A/S SPONS.ADR 1

F:NZM Germany Specialty Chemicals
Market Cap
$24.08 Billion
€20.60 Billion EUR
Market Cap Rank
#1087 Global
#248 in Germany
Share Price
€50.00
Change (1 day)
+0.00%
52-Week Range
€44.80 - €66.00
All Time High
€67.43
About

Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and … Read more